Buchumschlag

Quantitative analysis of SLC34A2 expression in different types of ovarian tumors

Aim: The main purpose of this study was to estimate the SLC34A2 gene expression in normal ovary and different types of ovarian tumors. Methods: We have investigated SLC34A2 gene expression level in papillary serous, endometrioid, unspecified adenocarcinomas, benign tumors, and normal ovarian tissues...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2011
Hauptverfasser:	Shyian, M., Gryshkova, V., Kostianets, O., Gorshkov, V., Goloev, Yu., Goncharuk, I., Nespryadko, S., Vorobjova, L., Filonenko, V., Kiyamova, R.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2011
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/138632
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Quantitative analysis of SLC34A2 expression in different types of ovarian tumors / M. Shyian, V. Gryshkova, O. Kostianets, V. Gorshkov, Yu. Goloev, I. Goncharuk, S. Nespryadko, L. Vorobjova, V. Filonenko, R. Kiyamova // Experimental Oncology. — 2011. — Т. 33, № 2. — С. 94-98. — Бібліогр.: 32 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

The study of phosphate transporter NaPi2b expression in different histological types of epithelial ovarian cancer
von: Gryshkova, V., et al.
Veröffentlicht: (2009)

Clinical significance of hormonal receptor status of malignant ovarian tumors
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Recurrence of borderline ovarian tumors
von: Svintsitskiy, V.S., et al.
Veröffentlicht: (2013)

Survivin expression in ovarian cancer
von: Liguang, Z., et al.
Veröffentlicht: (2007)

Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
von: Buchynska, L.G., et al.
Veröffentlicht: (2009)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
von: Kryzhanivska, A.E., et al.
Veröffentlicht: (2018)

Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
von: Ryabtseva, O.D., et al.
Veröffentlicht: (2013)

Expression OF p53, p21WAF1/CIP1 , p16INK4A and Ki-67 proteins in serous ovarian tumors
von: Buchynska, L.G., et al.
Veröffentlicht: (2007)

Immunohistochemical analysis of NaPi2b protein (MX35 antigen) expression and subcellular localization in human normal and cancer tissues
von: Kiyamova, R., et al.
Veröffentlicht: (2011)

Expression of cancer-associated genes in prostate tumors
von: Rosenberg, E.E., et al.
Veröffentlicht: (2017)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Quantitative real time PCR analysis of apoptosis-related gene expression in leukemias in ukrainian patients
von: Savli, H., et al.
Veröffentlicht: (2011)

Immunohistochemical analysis of beta-defensin-2 expression in human lung tumors
von: Shestakova, T., et al.
Veröffentlicht: (2010)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
von: Bereznaya, N.M., et al.
Veröffentlicht: (2008)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
von: Naleskina, L.A., et al.
Veröffentlicht: (2016)

Drug resistance associated properties of blasts subpopulations with different CD34 expression in childhood acute lymphoblastic leukemia (ALL)
von: Shman, T.V., et al.
Veröffentlicht: (2011)

Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer
von: Lurchenko, N.P., et al.
Veröffentlicht: (2014)

Comparison of various tissue and cell therapy approaches when restoring ovarian, hepatic and kidney’s function after chemotherapy-induced ovarian failure
von: Kozub, M.M., et al.
Veröffentlicht: (2017)

Analysis of P53, P16INK4A, PRB and cyclin D1 expression and human papillomavirus in primary ovarian serous carcinoma
von: Bilyk, O.O., et al.
Veröffentlicht: (2011)

Effects of alvocidib and carboplatin on ovarian cancer cells in vitro
von: Baumann, K.H., et al.
Veröffentlicht: (2013)

DNA damage in tumor cells and peripheral blood lymphocytes of endometrial cancer patients assessed by the comet assay
von: Buchynska, L.G., et al.
Veröffentlicht: (2017)

Cloning of variable fragments of tumor immunoglobulin, assembling and expressing of human SCFV protein in E. coli for anti-idiotype vaccination
von: Meleshko, A.N., et al.
Veröffentlicht: (2013)

Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion
von: Gerashchenko, G.V., et al.
Veröffentlicht: (2018)

Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
von: Bubnovskaya, L., et al.
Veröffentlicht: (2012)

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
von: Tkalia, I.G., et al.
Veröffentlicht: (2015)

Nanohyperthermia of malignant tumors.i. lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia
von: Solopan, S., et al.
Veröffentlicht: (2011)

In VIVO anti-tumor activities of gelatin
von: Inamura, Y., et al.
Veröffentlicht: (2009)

Establishment and characterization of new breast and ovarian cancer cell lines as a model for studying cellular plasticity in vitro
von: Bezdieniezhnykh, N., et al.
Veröffentlicht: (2016)

The long-range cytotoxic effect in tumor-bearing animals
von: Gerashchenko, B.I., et al.
Veröffentlicht: (2012)

IGHV3-21 gene expression in patients with b-cell chronic lymphocytic leukemia in Ukraine
von: Abramenko, I., et al.
Veröffentlicht: (2007)

The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer
von: Bilyk, O.O., et al.
Veröffentlicht: (2014)

Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
von: Yurchenko, O.V., et al.
Veröffentlicht: (2010)

Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

Microarray study of gene expression in uterine leiomyoma
von: Litovkin, K.V., et al.
Veröffentlicht: (2008)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
von: Lukyanova, N.Yu.
Veröffentlicht: (2010)

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
von: Sviezhentseva, I.O., et al.
Veröffentlicht: (2015)

Aspisol inhibits tumor growth and induces apoptosis in breast cancer
von: Zhu, X.G., et al.
Veröffentlicht: (2008)

Phenotypic features of endometrial tumors in patients with family history of cancer
von: Buchynska, L.G., et al.
Veröffentlicht: (2017)

Mutations in the gene of human type IIb sodium-phosphate cotransporter SLC34A2
von: Lituiev, D.S., et al.
Veröffentlicht: (2010)

Efficacy of natural L-asparagine in the complex therapy for malignant tumors in experimental studies
von: Urazova, L.N., et al.
Veröffentlicht: (2011)